Early drug and anti-infliximab antibody levels for prediction of primary nonresponse to infliximab therapy

H. Bar-Yoseph, N. Levhar, L. Selinger, U. Manor, M. Yavzori, O. Picard, E. Fudim, U. Kopylov, R. Eliakim, S. Ben-Horin, Y. Chowers, B. Ungar*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

64 Scopus citations

Fingerprint

Dive into the research topics of 'Early drug and anti-infliximab antibody levels for prediction of primary nonresponse to infliximab therapy'. Together they form a unique fingerprint.

Keyphrases

Immunology and Microbiology

Pharmacology, Toxicology and Pharmaceutical Science

Neuroscience